Jagwire M00556600Recalls & reported problems
Boston Scientific Corporation · High Performance Guidewire · Class 2
All models of Jagwire (11)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 08714729747246), received between Sep 12, 2017 and Aug 20, 2026 — classified as 4 injuries, 3 malfunctions.
The most frequently reported specific device problem is “Peeled/Delaminated” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Peeled/Delaminated3
- Adverse Event Without Identified Device or Use Problem1
- Break1
- Detachment Of Device Component1
- Device-Device Incompatibility1
- Material Deformation1
- Material Separation1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
- Foreign Body In Patient1
- Inflammation1
- Insufficient Information1
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
InjuryAug 20, 2026Device-Device Incompatibility; Material Deformation
Patient problems: Foreign Body In Patient
MAUDE report 50351124 ↗InjuryMay 31, 2023Break; Adverse Event Without Identified Device or Use Problem; Break; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A JAGWIRE WAS USED IN THE PANCREATIC DUCT DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE PERFORMED ON (B)(6) 2023. IT WAS REPORTED THAT WHEN THE JAGWIRE WAS PULLED THROUGH, THE COREWIRE BROKE AND REMAINED INSIDE THE PANCREATIC DUCT. REPORTEDLY, THE PATIENT STAYED LONGER AT THE HOSPITAL FOR FURTHER OBSERVATION AND WAS SENT FOR IMAGING. THE PROCEDURE WAS NOT COMPLETED DUE TO THIS EVENT. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17029827 ↗MalfunctionFeb 2, 2023Material Separation
DURING ATTEMPTED ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP), DOCTOR WAS USING THE ECHOTIP ULTRA 19-A WITH THE JAGWIRE STRAIGHT TIP 0.035 IN AND A PIECE OF THE HYDROPHILIC COATING WAS CUT OFF. UNABLE TO RETRIEVE THE COATING.
Patient problems: Insufficient Information
MAUDE report 16283340 ↗MalfunctionApr 28, 2022Peeled/Delaminated; Peeled/Delaminated
NOTES: THIS REPORT PERTAINS TO TWO SPYSCOPE DS II, ONE SPY DS CONTROLLER AND TWO JAGWIRES USED DURING THE SAME PROCEDURE. IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT TWO SPYSCOPE DS II, ONE SPY DS CONTROLLER AND TWO JAGWIRE GUIDEWIRES WERE USED IN THE BILIARY TRACT DURING A CHOLANGIOSCOPIC LITHOTRIPSY PROCEDURE PERFORMED ON (B)(6) 2022. DURING THE PROCEDURE, THE PHYSICIAN PUT A SPYSCOPE AND A JAGWIRE INTO THE BILIARY TRACT. DURING THE EXCHANGE, THE JACKET ON THE GUIDEWIRE STRIPPED AWAY FROM THE INNER SHAFT. THE SPYSCOPE COULD NOT BE BACK LOADED OVER THE GUIDEWIRE. A NEW JAGWIRE WAS USED TO CANNULATE AGAIN. WHEN CANNULATION WAS DONE AND THE PHYSICIAN TRIED TO EXCHANGE THE WIRE, THE WIRE STRIPPED AGAIN. THE PHYSICIAN TOOK OUT THE SPYSCOPE WITH THE GUIDEWIRE AND DECIDED NOT TO PROCEED WITH THE USE OF A GUIDEWIRE. THEN THE SPYSCOPE WAS REINSERTED AND DURING WATER INJECTION, THE SPYSCOPE STOPPED WORKING. THE SPYSCOPE WAS REPLACED WITH A SECOND SPYSCOPE BUT THE SAME PROBLEM OCCURRED. IT IS UNKNOWN IF THE PHYSICIAN WAS BLASTING STONES OR INJECTING WATER WHEN THE SECOND SPYSCOPE STOP WORKING. THE PROCEDURE WAS CHANGED TO A REGULAR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (E
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14244778 ↗MalfunctionApr 28, 2022Peeled/Delaminated; Peeled/Delaminated
NOTES: THIS REPORT PERTAINS TO TWO SPYSCOPE DS II, ONE SPY DS CONTROLLER AND TWO JAGWIRES USED DURING THE SAME PROCEDURE. IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT TWO SPYSCOPE DS II, ONE SPY DS CONTROLLER AND TWO JAGWIRE GUIDEWIRES WERE USED IN THE BILIARY TRACT DURING A CHOLANGIOSCOPIC LITHOTRIPSY PROCEDURE PERFORMED ON (B)(6) 2022. DURING THE PROCEDURE, THE PHYSICIAN PUT A SPYSCOPE AND A JAGWIRE INTO THE BILIARY TRACT. DURING THE EXCHANGE, THE JACKET ON THE GUIDEWIRE STRIPPED AWAY FROM THE INNER SHAFT. THE SPYSCOPE COULD NOT BE BACK LOADED OVER THE GUIDEWIRE. A NEW JAGWIRE WAS USED TO CANNULATE AGAIN. WHEN CANNULATION WAS DONE AND THE PHYSICIAN TRIED TO EXCHANGE THE WIRE, THE WIRE STRIPPED AGAIN. THE PHYSICIAN TOOK OUT THE SPYSCOPE WITH THE GUIDEWIRE AND DECIDED NOT TO PROCEED WITH THE USE OF A GUIDEWIRE. THEN THE SPYSCOPE WAS REINSERTED AND DURING WATER INJECTION, THE SPYSCOPE STOPPED WORKING. THE SPYSCOPE WAS REPLACED WITH A SECOND SPYSCOPE BUT THE SAME PROBLEM OCCURRED. IT IS UNKNOWN IF THE PHYSICIAN WAS BLASTING STONES OR INJECTING WATER WHEN THE SECOND SPYSCOPE STOP WORKING. THE PROCEDURE WAS CHANGED TO A REGULAR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (E
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14244711 ↗InjuryDec 4, 2018Peeled/Delaminated; Peeled/Delaminated
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A JAGWIRE WAS USED DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE PERFORMED ON (B)(6) 2018. ACCORDING TO THE COMPLAINANT, THE FIRST ERCP PROCEDURE WAS TO REMOVE STONES AND A PLASTIC STENT OUT OF THE COMMON BILE DUCT. IN ADDITION, CONCREMENTS WERE ALSO REMOVED WHICH HAD BEEN DISCOVERED BY THE APPLICATION OF CONTRAST AGENTS IN THE DISTAL PART OF THE COMMON BILE DUCT. THE CONCREMENTS WERE REMOVED USING A BASKET AND A BALLOON (MANUFACTURERS UNKNOWN). THEY USED CONTRAST MEDIUM IN THE FIRST ERCP BUT WITH CATHETER, PANCREAS HEAD AND CORPUS ARE NOT SELECTIVELY DISPLAYED WITHOUT LATERAL BRANCHES. A COMPLETE VISUALIZATION OF THE PANCREATIC DUCT WAS NOT INTENDED. THERE WERE NO REPORTED ISSUES WITH THE JAGWIRE. THE PATIENT WAS STABLE POST-PROCEDURE. A DAY LATER THE PATIENT'S CHOLESTASIS VALUES INCREASED. THEREFORE, A SECOND ERCP PROCEDURE WAS PERFORMED, DUE TO POST ERCP PANCREATITIS. CONTRAST MEDIUM WAS USED BUT A VISUALIZATION OF THE PANCREATIC DUCT WAS OMITTED. A 2CM PIECE OF THE JAGWIRE COATING WAS FOUND INSIDE THE BILE DUCT, AND WAS SUCCESSFULLY RETRIEVED USING A BALLOON CATHETER (MANUFACTURER UNKNOWN). IN THE
Patient problems: Inflammation
MAUDE report 8131389 ↗InjurySep 12, 2017Detachment Of Device Component; Detachment Of Device Component
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A JAGWIRE¿ WAS USED DURING AN ABDOMINAL AORTIC ANEURYSM REPAIR PROCEDURE PERFORMED VIA LEFT ARM BRACHIAL ACCESS ON (B)(6) 2017. ACCORDING TO THE COMPLAINANT, DURING THE PROCEDURE, THE JAGWIRE WAS ADVANCED INTO THE ABDOMINAL AORTA VIA FEMORAL ACCESS SHEATH. THE PHYSICIAN ADVANCED A SNARE INTO THE BRACHIAL ACCESS SHEATH AND SNARED THE JAGWIRE TO PULL THE WIRE OUT OF THE BRACHIAL SHEATH. REPORTEDLY, THE HYDROPHILIC TIP OF THE JAGWIRE CAME OFF WHICH WAS RECOVERED INSIDE THE HUB OF THE BRACHIAL SHEATH. THE PROCEDURE WAS COMPLETED WITH A SECOND JAGWIRE. ADDITIONALLY, THE DIRECTIONS FOR USE INDICATE "THE JAGWIRE HIGH PERFORMANCE GUIDEWIRE IS INDICATED FOR USE IN SELECTIVE CANNULATION OF THE BILIARY DUCTS INCLUDING, BUT NOT LIMITED TO THE COMMON BILE, CYSTIC, RIGHT AND LEFT HEPATIC DUCTS. THE JAGWIRE HIGH PERFORMANCE GUIDEWIRE IS DESIGNED TO BE USED DURING ENDOSCOPIC BILIARY PROCEDURES FOR CATHETER INTRODUCTION AND EXCHANGES. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. THE PATIENT'S CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE STABLE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6859669 ↗
Other Endoscopic guidewire, gastroenterology-urology devices
- HiWire G30474Cook Incorporated · Endoscopic guidewire, gastroenterology-urology82 reports
- Roadrunner G18154Cook Incorporated · Endoscopic guidewire, gastroenterology-urology1 recall18 reports
- Roadrunner G17542Cook Incorporated · Endoscopic guidewire, gastroenterology-urology1 recall9 reports
- Roadrunner G18153Cook Incorporated · Endoscopic guidewire, gastroenterology-urology1 recall6 reports
- Roadrunner G18155Cook Incorporated · Endoscopic guidewire, gastroenterology-urology1 recall3 reports
- Roadrunner G17539Cook Incorporated · Endoscopic guidewire, gastroenterology-urology1 recall2 reports
- Roadrunner G17540Cook Incorporated · Endoscopic guidewire, gastroenterology-urology1 recall0 reports
- Jagwire M00556580Boston Scientific Corporation · Endoscopic guidewire, gastroenterology-urology1 death49 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page